Over on InsideGoogle, we learn that:
Celebrex, the keyword, has soared, as personal injury attorneys scramble to buy the keyword for big bucks at Overture and AdWords, MarketWatch is reporting. The Overture cost of Celebrex soared from 95 cents on Friday to $4.02 today, following news that the FDA was considering regulatory measures for the best-selling arthritis drug.
Celebrex the arthritis drug?
I never really thought about how FDA action against particular drugs would affect keyword ad buys. Sure, I've seen how it affects the stock prices of drug companies, but this is a bit unexpected.
It's a brave new world, with new economies that are ripe for study.
Posted by jzawodn at December 20, 2004 11:39 PM